View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB42 | Publication ID: Spring 2017 |
Title: ●Implementation of the Comprehensive Addiction and Recovery Act of 2016 and the Department of Health and Human Services Regulations Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder | |
Abstract:
On July 22, 2016, the Comprehensive Addiction and Recovery Act of 2016 became law. One section of the CARA amended the Controlled Substances Act to expand the categories of practitioners who may, under certain conditions on a temporary basis, dispense a narcotic drug in schedule III, IV, or V for the purpose of maintenance treatment or detoxification treatment. Separately, the Department of Health and Human Services, by final rule effective August 8, 2016, increased to 275 the maximum number of patients that a practitioner may treat for opioid use disorder without being separately registered under the CSA for that purpose. By this rulemaking, DEA is amending its regulations to incorporate these statutory and regulatory changes.
|
|
Agency: Department of Justice(DOJ) | Priority: Substantive, Nonsignificant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1301 | |
Legal Authority: 21 U.S.C. 823 |
Legal Deadline:
|
||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Michael J. Lewis Section Chief Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 598-6812 Fax:202 307-9536 |